Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias

Clinical trial NCT00749112 · COMPLETED

Trial details

NCT number: NCT00749112
Sponsor: Hospital Universitario Dr. Jose E. Gonzalez
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Idiopathic Thrombocytopenic Purpura Anemia, Hemolytic, Autoimmune

Start date: 2008-08-01
Primary completion: 2010-08-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.